Home › Interstitial Lung Diseases › Arizona
Interstitial Lung Diseases clinical trials in Arizona
13 studies for Interstitial Lung Diseases are looking for participants at sites in Arizona.
Cities in Arizona
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA027, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Arizona Heart Rhythm Center, Phoenix
- University of Arizona, Tucson
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 29, 2026 · NCT05798923Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- Phoenix, Phoenix
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 8, 2026 · NCT07473700A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Scottsdale
- GSK Investigational Site, Scottsdale
- GSK Investigational Site, Tucson
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05878717Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Banner University Medical Center, Phoenix
- Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute, Phoenix
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix
- Arizona Pulmonary Specialists, Ltd., Scottsdale
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07285655DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Banner Health - University Medical Center Phoenix, Phoenix
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Arizona, Tucson
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Arizona Pulmonary Specialists, Phoenix
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Banner University Medical Center Phoenix Lung Institute, Phoenix
- Norton Thoracic Institute, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05943535An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Arizona Pulmonary Specialists, Phoenix
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Jun 26, 2026 · NCT06129240Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
- Mayo Clinic in Arizona, Scottsdale
Recruiting
Ages 18 and older · All sexes · Updated Mar 20, 2026 · NCT06751069Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- HonorHealth Research Institute, Scottsdale
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.